In a victory for Big Pharma, a federal court has rejected new rules issued by the USPTO that aimed to reduce the patent filing backlog by imposing limits on claims and continuations. The judge says that the the patent office exceeded its authority.
read more | digg story
Wednesday, April 2, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment